Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Targeting Impaired Type I Interferon-IL-27 Signaling Rescues T Regulatory Cell Suppressive Function in Relapsing-Remitting Multiple Sclerosis.
Journal: bioRxiv : the preprint server for biology
Published: March 05, 2026
Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients.
Journal: bioRxiv : the preprint server for biology
Published: January 23, 2024
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives.
Journal: Neurology and therapy
Published: July 26, 2023
IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 20, 2023
Corrigendum to "Oligoclonal myelin-reactive T-cell infiltrates derived from neuromyelitis optica spectrum disorder (NMOSD) lesions are enriched in Th17 cells" [Clinical Immunology 130 (2009) 133-144].
Journal: Clinical immunology (Orlando, Fla.)
Published: March 21, 2022
Dalfampridine for Mobility Limitations in People With Multiple Sclerosis May Be Augmented by Physical Therapy: A Non-randomized Two-Group Proof-of-Concept Pilot Study.
Journal: Frontiers in rehabilitation sciences
Published: October 14, 2021
Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 22, 2021
STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 24, 2020
The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation.
Journal: Immunity
Published: July 13, 2020
IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 14, 2019
Case Report: Combining Dalfampridine with Multicomponent Exercise and Gait Training in a Person with Multiple Sclerosis.
Journal: International journal of MS care
Published: October 31, 2018
IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.
Journal: Clinical immunology (Orlando, Fla.)
Published: June 06, 2018
Last Updated: 09/26/2026